Certified by Founder Lodge 
                                        
                                        xilis
 United States  -  Durham, North Carolina
 
                                                 United States  -  Durham, North Carolina 
                                             START UP 
                                                                                    1 Disclosed Funding Rounds $89,000,000
                                            0 Participating Investments
- 
                                                Founded date 
                                                2019 
- 
                                                Operating Status 
                                                Active 
- 
                                                Last Funding Type 
                                                Seed 
- 
                                                Company Type 
                                                For Profit 
- Website
- Contact
- Social Links
                                            Developing next generation technologies for precision medicine and drug discovery.
                                        
                                        
                                        
                                                                                
                                        
                                                                                | Date | Round | Raised | Participating Investors | 
|---|---|---|---|
| July, 13 ,2022 | Series A | $89,000,000 | 
 
                                                 GV (Google Ventures)
 GV (Google Ventures)
                                                                                 Pear VC
 Pear VC
                                                                                 Duke Capital Partners
 Duke Capital Partners
                                                                                 Mubadala Capital
 Mubadala Capital
                                                                                 
                                                                             FPV Ventures
 FPV Ventures
                                                                                 Felicis
 Felicis
                                                                                 Two Sigma Ventures
 Two Sigma Ventures
                                                                                 EQT Life Sciences
 EQT Life Sciences
                                                                                 
                                                                             Catalio Capital Management
 Catalio Capital Management
                                                                                 Alix Ventures
 Alix Ventures
                                                                                 IDRx
IDRx CAMP4 Therapeutics
CAMP4 Therapeutics Delfi Diagnostics
Delfi Diagnostics Manifold Bio
Manifold Bio Scorability |  $11,000,000  | (Oct 18, 2023)
                                                                        
                                Scorability |  $11,000,000  | (Oct 18, 2023) Hallmark Health Care Solutions |  Undisclosed Amount  | (Oct 18, 2023)
                                                                        
                                Hallmark Health Care Solutions |  Undisclosed Amount  | (Oct 18, 2023) Cloover |  $7,388,000  | (Oct 18, 2023)
                                                                        
                                Cloover |  $7,388,000  | (Oct 18, 2023) 
                             Yardstik |  $12,000,000  | (Oct 18, 2023)
                                                                        
                                Yardstik |  $12,000,000  | (Oct 18, 2023) Anonybit |  $3,000,000  | (Oct 18, 2023)
                                                                        
                                Anonybit |  $3,000,000  | (Oct 18, 2023) 
                                                 
                                                     
                                                 
                                                     
                                                 
                                                 
                                                     
                                                 
                                                 
                                                 
                                                     
                                                 
                                                